Pharmaceutical Research and Manufacturers of America (PhRMA) is a Washington, D.C.-based trade group that represents major drugmakers. Its filings show it lobbied Congress on health and drug-price rules, including pharmacy benefit manager (PBM) reform, the 340B drug pricing program, and Most-Favored-Nation prescription drug pricing. It spent about $200,000 across four filings and used Empire Consulting Group.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
E. BRANDON GARRETT
The latest disclosures for this client.
EMPIRE CONSULTING GROUP
Q3EMPIRE CONSULTING GROUP
Q2The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
EMPIRE CONSULTING GROUP
MIKE MCKAY
EMPIRE CONSULTING GROUP
MICHAEL HAYES
EMPIRE CONSULTING GROUP
BRIAN GREER
EMPIRE CONSULTING GROUP
EMPIRE CONSULTING GROUP
Q1EMPIRE CONSULTING GROUP
Q4EMPIRE CONSULTING GROUP
Q3EMPIRE CONSULTING GROUP
Q2EMPIRE CONSULTING GROUP
Q1